🔎 Trials Near Me

Hjem › Ulcerøs colitis › Washington › Tacoma

Ulcerøs colitis kliniske forsøg i Tacoma, WA

15 studier for Ulcerøs colitis søger deltagere på steder i og omkring Tacoma (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

RekruttererFase 3
  • Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
Alle aldre · Alle køn · Opdateret 2. okt. 2026 · NCT06651281

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

RekruttererFase 2
  • Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07697456

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

RekruttererFase 2
  • Site 019, Tacoma
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

RekruttererFase 2
  • Site US-029, Tacoma
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07845487

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

RekruttererFase 3
  • GI Alliance Tacoma, Tacoma
Alder 12 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07196748

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

RekruttererFase 2/3
  • MultiCare Health System, Tacoma
Alder 2 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

RekruttererFase 3
  • Washington Gastroenterology - Tacoma, Tacoma
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937086

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

RekruttererFase 2
  • Washington Gastroenterology - Tacoma, Tacoma
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

RekruttererFase 4
  • Washington Gastroenterology- GIA, Tacoma
Alder 18 til 65 · Alle køn · Opdateret 21. sep. 2026 · NCT06095128

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

RekruttererFase 3
  • GI Alliance Tacoma, Tacoma
Alder 18 og opefter · Alle køn · Opdateret 28. aug. 2026 · NCT07577856

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

RekruttererFase 2
  • Digestive Health Specialists, Tacoma
Alder 18 til 80 · Alle køn · Opdateret 21. aug. 2026 · NCT06636656

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

RekruttererFase 3
  • MultiCare Institute for Research & Innovation, Tacoma
Alder 2 til 17 · Alle køn · Opdateret 3. aug. 2026 · NCT06100289

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

RekruttererObservationsstudie
  • Washington Gastroenterology, Tacoma
Alder 18 til 64 · Alle køn · Opdateret 9. jul. 2026 · NCT06398626

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

RekruttererFase 3
  • Multicare Health System Institute for Research and Innovation, Tacoma
Alder 2 til 17 · Alle køn · Opdateret 22. jun. 2026 · NCT06405087

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

RekruttererFase 2
  • Mirador Therapeutics Selected Site, Tacoma
Alder 18 til 80 · Alle køn · Opdateret 12. mar. 2026 · NCT07113522

Ulcerøs colitis forsøg i andre byer

Andre studier i Tacoma

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.